Economic Bottlenecks: Overcoming Obstacles in Healthcare.
Hospitals and rehabilitation clinics operate in a challenging environment. Profitable operations are becoming increasingly difficult. Our restructuring experts help you unlock new value creation opportunities and minimize subsequent risks.
Whether a church-run acute care hospital or a private rehabilitation facility: What unites these institutions is not only increasing price and competitive pressure but also chronic underfunding. Most attempts to improve the economic situation fail due to the heterogeneous ownership structure. Meanwhile, one in every four facilities is fighting for survival. The situation in care facilities has also been increasingly tense for years.
What's crucial now is an unsparing look at the numbers. If the company's results are negative, restructuring must start as soon as possible: operationally, but also in terms of the balance sheet capital structures. Our methods for improving earnings and liquidity are proven. Above all, they are effective quickly.
With us, you have a partner by your side that isn't easily unsettled by a crisis.
The framework conditions in healthcare are pushing economic viability to its limits.Uwe Köstens, Founder and Managing Partner, Head of Real EstateUwe Köstens, Founder and Managing Partner, Head of Real Estate View Uwe Kösten´s Profile
We help you refine your strategic priorities, tap into growth potential, and boost profitability and operational performance. Together, we create a solid foundation for decision-making, translate it into clear actions, and consistently implement changes in your organization, processes, and management systems.
We support companies, shareholders, and investors in acquisitions, divestitures, succession planning, and carve-outs—from deal readiness and transaction strategy through valuation and due diligence to negotiations, closing, and integration. In this way, we enhance transaction certainty and create the conditions necessary to realize the targeted value through operational performance.
We support companies, shareholders, and investors in acquisitions, divestitures, succession planning, and carve-outs—from deal readiness and transaction strategy through valuation and due diligence to negotiations, closing, and integration. In this way, we enhance transaction certainty and lay the groundwork for realizing the targeted value through operational performance.
We fill C-level and business-critical leadership roles during periods of transformation, growth, and restructuring—whether on a permanent, interim, or hybrid basis. In doing so, we combine executive search with a deep understanding of the strategic and operational context. This ensures that the candidate’s personality, the assignment, and the role are a good fit, and that companies remain capable of taking action.
We align strategic goals with digital business models, high-performing processes, and clear technological priorities. Together, we identify business-relevant use cases, create scalable structures, and support implementation—so that digital transformation and AI can boost productivity, unlock new growth potential, and secure competitive advantages.
We support developers, investors, and financing partners throughout the entire project lifecycle—from feasibility and risk analyses to financing and project management, all the way through to strategic realignment in challenging situations. In doing so, we integrate real estate, financial, and operational perspectives to stabilize projects, support decision-making, and realize value potential.
We support companies through strategic realignment, operational transformation, and financial restructuring. Together, we create transparency, stabilize earnings and liquidity, realign business models and organizational structures, and consistently implement measures—with clear governance, measurable progress, and accountability—until the impact is evident in day-to-day operations.
We develop sustainable capital structures for growth, transformation, and special situations—from growth financing and refinancing to debt restructuring. Together, we create transparency regarding liquidity and capital requirements, evaluate financing options, and manage negotiations with banks and other lenders through to the finalization of binding agreements.
Volatile demand, intensified competition from China, regulatory uncertainty, and high investment requirements are forcing OEMs and suppliers to realign their portfolios, locations, and capital. We create a solid foundation for decision-making, strengthen cost efficiency and performance, and manage the implementation process in collaboration with customers, financing partners, and employee representatives.
Cautious investment, rising location costs, and trade policy risks are weighing on capacity utilization and margins. At the same time, customers expect shorter payback periods, reliable delivery capabilities, and digital services. We are sharpening our market positioning and portfolio, improving project margins and working capital, and translating technology and service potential into robust earnings contributions.
Fluctuating freight demand is compounded by rising labor, energy, and toll costs, infrastructure bottlenecks, and geopolitical reroutes. Shippers nevertheless expect reliable capacity, transparent shipment data, and measurable progress toward decarbonization. We optimize networks and cost structures, improve planning and management using data and AI, and consistently implement operational improvements.
Financing costs, volatile valuations, construction costs, and regulations are putting pressure on project developers, property owners, construction companies, and financiers. Changing usage requirements and ESG guidelines are increasingly determining the profitability of locations and portfolios. We provide transparency regarding values and risks, develop viable strategies, and consistently execute financing, transformation, and transactions.
Chemical companies face significant energy and cost pressures; pharmaceutical companies face development risks, price pressures, and regulatory challenges. Customers, government agencies, payers, and patients expect security of supply, sustainability, and transparency. We refine investment and portfolio decisions, strengthen operational performance, and consistently implement changes.
Chemical companies must reassess their energy-intensive capacities and portfolios; pharmaceutical companies face high development risks, pricing and reimbursement pressures, and stringent regulation. At the same time, customers, regulatory agencies, payers, and patients have increasingly high expectations regarding supply security, sustainability, and transparency. We refine investment decisions, enhance operational performance, and consistently implement changes throughout the value chain.
Pressure for reform, a shortage of skilled workers, the shift toward outpatient care, and the need for digital investment are increasing the pressure for change on hospitals, long-term care providers, and other healthcare organizations. Patients and employees expect quality and reliability; payers, owners, and policymakers expect both transparency and cost-effectiveness. We create a solid foundation for decision-making, develop sustainable care and operational models, and consistently implement restructuring and transformation.
Volatile demand, high price sensitivity, rising costs, and complex supply chains are putting pressure on margins. At the same time, platforms, private labels, and data-driven business models are shifting the balance of power between manufacturers, retailers, and consumers. We refine positioning and portfolios, optimize pricing, sales, and value creation, and scale digital and AI-driven processes.
Generative AI is accelerating innovation cycles and transforming search, distribution, and monetization. Media companies are competing on platforms for reach, willingness to pay, and user retention; technology providers must simultaneously master scaling, differentiation, regulation, and cybersecurity. We refine portfolios and business models, prioritize investments, and consistently align data, technology, and organization toward profitable growth.
Volatile demand, a shortage of skilled workers, rising operating costs, and significant investment needs are putting pressure on margins. Guests expect seamless digital services, compelling experiences, and a good value for money; owners and investors expect a robust economic outlook. We are refining our positioning and portfolio of offerings, optimizing revenue management and cost structures, and consistently implementing changes.
Transformation & Restructuring
Dass sich die Krise erst jetzt, knapp drei Jahre nach Ausbruch der Pandemie, in Bilanz, GuV und Cashflow der Unternehmen bemerkbar macht, ist auch auf die nach wie vor gestörten Lieferketten zurückzuführen. Materialknappheit und fehlende oder immer teurere Transportkapazitäten vor allem aus Asien beeinträchtigen den Zufluss von Produkten und Teilen. Um in dieser Situation eine verlässliche Warenversorgung sicherzustellen, haben viele Unternehmen große Sicherheitsbestände aufgebaut. Auch das bindet ordentlich Liquidität.
Transformation & Restructuring
The global economy is struggling hard with Covids consequences as the pandemic moves through its third year. What’s more the crisis mountain of supply chain stoppages, material and personnel shortages continues to grow: high energy and material costs are looming. In addition to all of this, cyber-attacks have now thrust forward, advancing to become our next big challenge. "A toxic cocktail," is how Uwe Köstens, founding partner of enomyc, sums up the situation. Crisis is his business: he has been advising on SME issues for more than 22 years. As a result, he is very knowledgeable about the effects crises have on the global economy. But what makes the current situation so dangerous? What in particular puts the eye on red alert? And how on earth can companies manage a less bumpy landing in the new reality called "crisis"? An interview.
Transformation & Restructuring
In recent months, many small and medium-sized enterprises (SMEs) have faced existential crises due to challenging economic conditions, the unique structural situation in Germany, and the lasting effects of the COVID-19 pandemic. The situation has been further exacerbated by sharply rising capital costs, increased risk aversion among financiers, and repayment obligations from the pandemic period. According to enomyc author Dr. Stefan Frings, these multiple crises present the perfect opportunity for decisive and consistent action. Often, it takes significant pressure before stakeholders are willing to confront harsh realities and, with careful consideration, bring an end to long-standing but unsustainable practices.
Strategy & Corporate Performance
It’s a horror scenario for any company: losing one your highest-revenue customers. The management wants to know how the loss will affect the operating result. The consequences for turnover, inventory, material and personnel costs also need to be identified as quickly as possible. In theory, this is the time for management control. In practice, however, this is often hopelessly overwhelmed. In his article, enomyc author Peter Kink describes how companies can quickly gain an overview with targeted mass data analysis. And why, despite everything, corporate management remains a managerial domain.
Transformation & Restructuring
The Corona pandemic and its consequences, including disruption of important supply chains and shortages of materials, have plunged many companies into a crisis that threatens their very existence. Small and medium-sized companies in particular are having to contend with double-digit falls in sales and earnings. Companies that failed to prepare for the crisis in good times have been hit particularly hard. So it's high time to tackle the issue of preventive restructuring now. In particular, products with an insufficient contribution to earnings, inefficient processes and cumbersome decision-making structures often lead to problems: While they can still be compensated for in good economic times, they can quickly become a threat to the company's existence in a crisis. In this situation, companies that see the crisis as an opportunity to anticipate necessary changes and implement them quickly have a clear advantage. The goal is to improve effectiveness, increase efficiency, launch growth initiatives and increase liquidity . The necessary measures should be taken proactively, quickly and thoroughly before liquidity bottlenecks force the company even further into the defensive. The first essential prerequisite to get back on the road to success is an unsparing look at the actual situation of the company with all its strengths, weaknesses, opportunities and risks.
Strategy & Corporate Performance
At first glance, the German MedTech industry seems to be doing well. It appears resilient in crises, innovative, strong in exports, and optimistic. However, on a global scale, its business growth seems to have slowed. What’s troubling the MedTech industry? How is its innovative strength holding up? And what about its future? enomyc, in collaboration with the German industry association SPECTARIS, which focuses on optics, photonics, analytical, and medical technology, surveyed over 40 companies in the industry. In this expert interview with Christian Zeller, we explore the sentiment, strengths, and levers of the German MedTech industry.
